Percheron Therapeutics (AU:PER) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Percheron Therapeutics Limited has announced the issuance of 6 million unquoted options, exercisable at $0.083 per share, set to mature by July 2029. These options are part of prior transactions and are not intended for public trading on the ASX. This strategic move could potentially influence the company’s stock dynamics and attract investor attention.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
